Literature DB >> 19096693

Brucellar spondylitis.

Hong Jae Lee1, Jin Woo Hur, Jong Won Lee, Sang Rok Lee.   

Abstract

The incidence of Brucellosis is increasing in Korea. Spondylitis is the most frequent complication, but it is difficult to diagnose because its clinical symptoms are non-specific. It should therefore be included in the differential diagnosis of back pain. We report three rare cases of brucellar spondylitis successfully treated by medical and surgical therapy.

Entities:  

Keywords:  Brucellosis; Spondylitis

Year:  2008        PMID： 19096693      PMCID： PMC2588316          DOI： 10.3340/jkns.2008.44.4.277

Source DB:  PubMed          Journal:  J Korean Neurosurg Soc        ISSN： 1225-8245


  11 in total

1.  Tuberculous, brucellar and pyogenic spondylitis: comparison of magnetic resonance imaging findings and assessment of its value.

Authors:  Mehmet Halit Yilmaz; Bilgül Mete; Faith Kantarci; Resat Ozaras; Harun Ozer; Ali Mert; Ismail Mihmanli; Recep Ozturk; Kaya Kanbergoglu
Journal:  South Med J       Date:  2007-06       Impact factor: 0.954

2.  Brucellar spondylo-discitis with rapidly progressive spinal epidural abscess presenting with sciatica.

Authors:  K Z Yuksel; M Senoglu; M Yuksel; M Gul
Journal:  Spinal Cord       Date:  2006-05-09       Impact factor: 2.772

3.  Brucellar spondylitis: review of 25 cases.

Authors:  Emel Yilmaz; Mufit Parlak; Halis Akalin; Yasemin Heper; Cuneyt Ozakin; Resit Mistik; Barbaros Oral; Safiye Helvaci; Okan Töre
Journal:  J Clin Rheumatol       Date:  2004-12       Impact factor: 3.517

Review 4.  Brucellar spondylitis: review of 35 cases and literature survey.

Authors:  J Solera; E Lozano; E Martínez-Alfaro; A Espinosa; M L Castillejos; L Abad
Journal:  Clin Infect Dis       Date:  1999-12       Impact factor: 9.079

5.  Brucellar spondylodiscitis: a case report.

Authors:  G Aydin; A Tosun; I Keles; E Ayaşlioglu; O Tosun; S Orkun
Journal:  Int J Clin Pract       Date:  2006-03-27       Impact factor: 2.503

6.  Comparison of five antimicrobial regimens for the treatment of brucellar spondylitis: a prospective, randomized study.

Authors:  Y Bayindir; E Sonmez; A Aladag; N Buyukberber
Journal:  J Chemother       Date:  2003-10       Impact factor: 1.714

7.  A case of brucella spondylodiscitis with extended, multiple-level involvement.

Authors:  Mehmet Ozden; Kutbettin Demirdag; Ahmet Kalkan; Huseyin Ozdemir; Pinar Yuce
Journal:  South Med J       Date:  2005-02       Impact factor: 0.954

8.  Brucellar spondylitis.

Authors:  Hürrem Bodur; Ayse Erbay; Aylin Colpan; Esragül Akinci
Journal:  Rheumatol Int       Date:  2003-07-16       Impact factor: 2.631

9.  Brucellar spondylodiscitis in the lumbar region.

Authors:  Mehmet Turgut; Omer Faruk Sendur; Mustafa Gürel
Journal:  Neurol Med Chir (Tokyo)       Date:  2003-04       Impact factor: 1.742

10.  A comparative analysis of tuberculous, brucellar and pyogenic spontaneous spondylodiscitis patients.

Authors:  Tuba Turunc; Yusuf Ziya Demiroglu; Hikmet Uncu; Sule Colakoglu; Hande Arslan
Journal:  J Infect       Date:  2007-06-07       Impact factor: 6.072
View more
  4 in total

1.  Back pain secondary to Brucella spondylitis in the lumbar region.

Authors:  Kil-Byung Lim; Yee-Gyung Kwak; Dug-Young Kim; Young-Sup Kim; Jeong-A Kim
Journal:  Ann Rehabil Med       Date:  2012-04-30

2.  Cervical Spine Spondylitis with an Epidural Abscess in a Patient with Brucellosis: A Case Report.

Authors:  Mohammad Reza Hasanjani Roushan; Soheil Ebrahimpour; Zeinab Mohseni Afshar; Arefeh Babazadeh
Journal:  J Crit Care Med (Targu Mures)       Date:  2019-08-09

3.  Surgical management of cervical spinal epidural abscess caused by Brucella melitensis : report of two cases and review of the literature.

Authors:  Mehmet Ali Ekici; Zühtü Ozbek; Abdülkerim Gökoğlu; Ahmet Menkü
Journal:  J Korean Neurosurg Soc       Date:  2012-06-30

4.  The Evaluation of the Clinical, Laboratory, and Radiological Findings of 16 Cases of Brucellar Spondylitis.

Authors:  Baohui Yang; Hongbo Hu; Jie Chen; Xijing He; Haopeng Li
Journal:  Biomed Res Int       Date:  2016-09-08       Impact factor: 3.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.